<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView%20%20&amp;noscript=1">

PR6512

Model Information:

Castrate-resistant prostate cancer (CRPC).
Summary  
Cancer Type Prostate Cancer
Grade NA
Stage G4+5, T4, N1
Ethnicity Western
Gender M
Age 78
Pathology Diagnosis Castrate-resistant prostate cancer (CRPC).
Biopsy Site primary
Treatment History HT
Pathology QC Poorly differentiated carcinoma with massive necrosis(PR6511-H455/4 30/8), poorly differentiated carcinoma with part of papillary structure (PR6511-H455/4+C 8/11), poorly differentiated prostate adenocarcinoma; P504(2~3+), 34bE12(nearly 1~2%: 1+), CK8(3+), PSA(1~2+), Nkx3.1(3+), AR(3+), p63(1+).
Special Features CRPC, model expansion is needed prio to study.
Mouse Strain Rag2-/-?C-/-, NSG
TMA NA
Viral Status in PDX NA
Available In CB_UK
RNA Seq P4
Exome Seq P3

Growth Characteristics

Additional Characteristics

Create Account to View All Model Data

Already Registered? Login